304 related articles for article (PubMed ID: 12882930)
1. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine.
Babaei-Jadidi R; Karachalias N; Ahmed N; Battah S; Thornalley PJ
Diabetes; 2003 Aug; 52(8):2110-20. PubMed ID: 12882930
[TBL] [Abstract][Full Text] [Related]
2. The potential role of thiamine (vitamin B1) in diabetic complications.
Thornalley PJ
Curr Diabetes Rev; 2005 Aug; 1(3):287-98. PubMed ID: 18220605
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of thiamine therapy for prevention and treatment of early-stage diabetic nephropathy.
Rabbani N; Thornalley PJ
Diabetes Obes Metab; 2011 Jul; 13(7):577-83. PubMed ID: 21342411
[TBL] [Abstract][Full Text] [Related]
4. Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose.
Berrone E; Beltramo E; Solimine C; Ape AU; Porta M
J Biol Chem; 2006 Apr; 281(14):9307-13. PubMed ID: 16452468
[TBL] [Abstract][Full Text] [Related]
5. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.
Hammes HP; Du X; Edelstein D; Taguchi T; Matsumura T; Ju Q; Lin J; Bierhaus A; Nawroth P; Hannak D; Neumaier M; Bergfeld R; Giardino I; Brownlee M
Nat Med; 2003 Mar; 9(3):294-9. PubMed ID: 12592403
[TBL] [Abstract][Full Text] [Related]
6. Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat.
Balakumar P; Chakkarwar VA; Singh M
Mol Cell Biochem; 2009 Jan; 320(1-2):149-62. PubMed ID: 18830571
[TBL] [Abstract][Full Text] [Related]
7. Increased protein damage in renal glomeruli, retina, nerve, plasma and urine and its prevention by thiamine and benfotiamine therapy in a rat model of diabetes.
Karachalias N; Babaei-Jadidi R; Rabbani N; Thornalley PJ
Diabetologia; 2010 Jul; 53(7):1506-16. PubMed ID: 20369223
[TBL] [Abstract][Full Text] [Related]
8. High-dose thiamine therapy counters dyslipidemia and advanced glycation of plasma protein in streptozotocin-induced diabetic rats.
Karachalias N; Babaei-Jadidi R; Kupich C; Ahmed N; Thornalley PJ
Ann N Y Acad Sci; 2005 Jun; 1043():777-83. PubMed ID: 16037305
[TBL] [Abstract][Full Text] [Related]
9. The multifaceted therapeutic potential of benfotiamine.
Balakumar P; Rohilla A; Krishan P; Solairaj P; Thangathirupathi A
Pharmacol Res; 2010 Jun; 61(6):482-8. PubMed ID: 20188835
[TBL] [Abstract][Full Text] [Related]
10. Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycaemia by thiamine in vitro.
Thornalley PJ; Jahan I; Ng R
J Biochem; 2001 Apr; 129(4):543-9. PubMed ID: 11275553
[TBL] [Abstract][Full Text] [Related]
11. Detection of transketolase in bone marrow-derived insulin-producing cells: benfotiamine enhances insulin synthesis and glucose metabolism.
Oh SH; Witek RP; Bae SH; Darwiche H; Jung Y; Pi L; Brown A; Petersen BE
Stem Cells Dev; 2009; 18(1):37-46. PubMed ID: 18393672
[TBL] [Abstract][Full Text] [Related]
12. Boosting the pentose phosphate pathway restores cardiac progenitor cell availability in diabetes.
Katare R; Oikawa A; Cesselli D; Beltrami AP; Avolio E; Muthukrishnan D; Munasinghe PE; Angelini G; Emanueli C; Madeddu P
Cardiovasc Res; 2013 Jan; 97(1):55-65. PubMed ID: 22997160
[TBL] [Abstract][Full Text] [Related]
13. Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitro.
Schmid U; Stopper H; Heidland A; Schupp N
Diabetes Metab Res Rev; 2008; 24(5):371-7. PubMed ID: 18384109
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats.
Stracke H; Hammes HP; Werkmann D; Mavrakis K; Bitsch I; Netzel M; Geyer J; Köpcke W; Sauerland C; Bretzel RG; Federlin KF
Exp Clin Endocrinol Diabetes; 2001; 109(6):330-6. PubMed ID: 11571671
[TBL] [Abstract][Full Text] [Related]
15. High thiamine diphosphate concentrations in erythrocytes can be achieved in dialysis patients by oral administration of benfontiamine.
Frank T; Bitsch R; Maiwald J; Stein G
Eur J Clin Pharmacol; 2000 Jun; 56(3):251-7. PubMed ID: 10952481
[TBL] [Abstract][Full Text] [Related]
16. Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis.
Gadau S; Emanueli C; Van Linthout S; Graiani G; Todaro M; Meloni M; Campesi I; Invernici G; Spillmann F; Ward K; Madeddu P
Diabetologia; 2006 Feb; 49(2):405-20. PubMed ID: 16416271
[TBL] [Abstract][Full Text] [Related]
17. High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats.
Babaei-Jadidi R; Karachalias N; Kupich C; Ahmed N; Thornalley PJ
Diabetologia; 2004 Dec; 47(12):2235-46. PubMed ID: 15662560
[TBL] [Abstract][Full Text] [Related]
18. Antiglycation activity of thiamin-HCl and benfotiamine in diabetic condition.
Kousar S; Sheikh MA; Asghar M
J Pak Med Assoc; 2012 Oct; 62(10):1033-8. PubMed ID: 23866441
[TBL] [Abstract][Full Text] [Related]
19. Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-alpha.
Wu S; Ren J
Neurosci Lett; 2006 Feb; 394(2):158-62. PubMed ID: 16260089
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathy.
Alkhalaf A; Klooster A; van Oeveren W; Achenbach U; Kleefstra N; Slingerland RJ; Mijnhout GS; Bilo HJ; Gans RO; Navis GJ; Bakker SJ
Diabetes Care; 2010 Jul; 33(7):1598-601. PubMed ID: 20413516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
